先看重點
在聯邦合格健康中心進行的6個月試點中,納入分析的無線組86%(63/73)上傳了多次讀數,60名問卷應答者中95%(n=57)認為裝置易於使用。血壓結果僅為探索性且未設計足夠把握度,各組分配人數也未保留,因此無法判斷療效。
證據類型
隨機對照試驗
解讀依據
公開摘要
閱讀重點
對照與不確定性
研究在問什麼
僅約一半高血壓成人血壓得到控制,低收入和少數族裔族群差距更大。無線家庭監測可能有幫助,但在以西班牙裔為主的醫療資源不足族群中證據很少。作者主要檢驗無線監測在這一族群中是否可行、能否被接受。
研究對象與方法
隨機對照試點試驗,共6個月,巢狀於聖迭戈「無心臟病與中風區」專案,涉及3個聯邦合格健康中心網路。納入18歲及以上血壓未控制或新診斷的高血壓患者(血壓不低於140/90 mm Hg),按1:1簡單隨機分配至無線監測組(藍芽血壓計和蜂窩網路集線器,健康教練每週檢視上傳的彙總)或普通家庭監測組(紙質記錄)。兩組均接受標準化健康指導。可行性為預期210次讀數中被上傳的比例,可接受性為無線組治療後的滿意度問卷。血壓比較為探索性分析,僅限測量次數超過2次的參與者。
主要發現
以下為作者報告的結果。數值須連同族群和不確定性一起閱讀。
- 1316名入組者中290名(92%)符合條件,200名(63%)納入分析:無線組73名,常規組127名。平均年齡61歲(標準差9.1),女性佔57%(115/200),51%(n=102)為西班牙裔。
- 2無線組86%(63/73)上傳了多次讀數(平均160.6,標準差129.1),占上傳者預期讀數的76.2%(160/210),佔全部73人的66%;常規組僅5%(7/127)交回紙質記錄。
- 360名應答者(應答率82.2%)中,95%(n=57)同意或非常同意裝置易於設定和使用。
- 4兩組6個月時組內血壓均顯著下降(P <.001)。收縮壓<140 mm Hg者無線組為63%(46/73),常規組為74%(94/127)(P =.08;校正比值比,常規組對無線組,1.6,95%置信區間0.78-3.4;P =.19),這不能證明兩種方式等效。
限制與不確定性
- 1僅200名隨機入組者被分析,各組分配人數未保留,因此無法估計全部隨機入組者的可行性。
- 2分析限於測量次數超過2次的參與者,且常規組(127名)遠多於無線組(73名),可能使比較產生偏倚。
- 3可接受性僅來自無線組60名應答者的問卷,沒有對照組。
- 4作者說明血壓比較未設計足夠把握度;本解讀僅基於摘要。
日常健康啟示
在社群醫療中心,無線血壓計對不少人是可行的,多數應答者覺得易用。但研究沒有說明它降壓效果是否優於或不如紙質記錄。血壓治療的調整應由你和醫師決定。
如何連結自己的資料
如果你使用藍芽血壓計,自動同步的定期讀數正是這項試點所檢驗的資料。請使用同一臺血壓計、同樣的姿勢和時間,向醫師展示每週平均值和趨勢,而不是單次讀數。
如何理解這類證據
隨機分組有助於因果推斷,仍須檢查分配、盲法、失去追蹤、追蹤時間和具體對照;標為隨機試驗不自動意味著高確定性。
作者的結構化摘要 English
以下英文摘要依所記錄的開放授權轉載,屬於作者原始材料,並非 MoveVitals 解讀。上方已提供研究解讀,分別說明作者結果與本站解釋;重要結論可直接查核原文。
Background
Only approximately half of adults with hypertension, a leading cardiovascular risk factor, achieve blood pressure (BP) control, with persistent disparities among low-income and minority populations. Wireless home BP monitoring (HBPM) with remote patient monitoring can improve BP control, but evidence is limited in medically underserved, predominantly Hispanic populations served by federally qualified health centers (FQHCs).
Objective
The primary objective was to evaluate the feasibility and acceptability of wireless HBPM among predominantly Hispanic adults with hypertension receiving FQHC care. Comparing BP outcomes between wireless and conventional HBPM was a secondary exploratory objective.
Methods
We conducted a 6-month, 2-arm randomized controlled pilot feasibility and acceptability trial nested within the San Diego: Heart Attack and Stroke Free Zone program. Adults aged ≥18 years with uncontrolled or newly diagnosed hypertension (BP ≥140/90 mm Hg) were enrolled across 3 FQHC networks and randomized 1:1 by unrestricted simple randomization to wireless HBPM (Bluetooth cuff and cellular hub; weekly transmitted summaries reviewed by health coaches) or standard HBPM (home monitor with paper log). Both arms received standardized health coaching. The primary outcomes were feasibility (proportion of 210 expected BP readings transmitted) and acceptability (postintervention satisfaction survey in the wireless arm). Exploratory analyses compared BP outcomes between arms among participants with >2 BP measurements.
Results
Of 316 recruited participants, 290 (92%) were eligible, and 200 (63%) were analyzed (wireless: n=73, 23%; and standard: n=127, 40%); arm-level allocation counts were not retained. The mean age was 61 years (SD 9.1), 57% (115/200) were women, and 51% (n=102) self-identified as Hispanic, with no significant baseline differences between arms. Among analyzed wireless-arm participants, 86% (63/73) transmitted multiple readings (mean 160.6, SD 129.1) over 6 months, corresponding to 76.2% (160/210) of expected readings among transmitting participants and 66% across all 73; only 5% (7/127) of standard-arm participants returned paper logs. Of 60 respondents (82.2% response rate), 95% (n=57) agreed or strongly agreed that the device was easy to set up and use. Both arms showed significant within-arm BP reductions at 6 months ( P <.001). At 6 months, 63% (46/73) of the wireless arm and 74% (94/127) of the standard arm achieved systolic BP <140 mm Hg ( P =.08; adjusted odds ratio, standard vs wireless, 1.6, 95% CI 0.78-3.4; P =.19). These exploratory comparisons were not powered and do not constitute evidence of equivalence.
Conclusions
Among analyzed participants, wireless HBPM was feasible, and survey respondents reported high acceptability in a medically underserved, predominantly Hispanic FQHC population. Feasibility among all randomized participants could not be estimated because arm-level allocation counts were not retained. The absence of a between-arm difference in BP control is not evidence of equivalence because this pilot was not powered to compare clinical effectiveness; the BP findings are hypothesis generating.
來源與署名
Wireless Home Blood Pressure Monitoring With Health Coaching for Hypertension Management at a Federally Qualified Health Center: Pilot Randomized Controlled Feasibility and Acceptability Study.
Magalit N, Moran R, Narezkina A, Patrick K, DeMaria A.
JMIR formative research · 2026-10-22
DOI: 10.2196/100115 ↗PubMed · 42912953 ↗Europe PMC · 所記錄的開放授權: cc by ↗摘要著作權歸原作者,依來源紀錄的開放授權轉載。中文譯文協助閱讀,英文摘要供查核術語及具體數值;本站的方法學解釋與作者結論分別呈現。
MoveVitals 編輯解讀 · 健康教育內容 · 未記錄個人臨床審閱
來源查核日期 2026-11-01
實用健康指南
放在一起讀
晝夜活動節律紊亂與更高的死亡風險相關(109,365人)
在7項觀察性研究、共109,365名參與者中,晝夜活動對比較弱(相對振幅較低)與更高的心血管死亡風險(風險比[HR]1.50,95%置信區間1.13至1.98)和全因死亡風險(HR 1.46,95%置信區間1.27至1.68)相關。證據基礎小,又是觀察性的,不能說明改善節律就能降低風險,疾病本身也可能擾亂節律。
Journal of the American Heart Association
五類運動都降低了靜息血壓,等長訓練降幅最大
彙總270項隨機試驗、共15,827名參與者的結果,有氧、抗阻、聯合、間歇和等長訓練與無介入對照組相比都降低了靜息血壓(各P<0.001),其中等長訓練降幅最大:收縮壓下降8.24 mm Hg,舒張壓下降4.00 mm Hg。各方式之間的排序部分來自間接比較,各試驗也不盡相同,所以排序不是個人的運動處方。
British Journal of Sports Medicine
鹽替代品使中國農村高危族群的中風、主要心血管事件和死亡率下降
在中國農村600個村莊、20,995名有中風史或年齡在60歲及以上且有高血壓的人中,使用鹽替代品(氯化鈉75%、氯化鉀25%)的中風發生率低於普通鹽:平均追蹤4.74年,每1000人年29.14次對33.65次(率比0.86,95%置信區間0.77至0.96;P=0.006)。死亡也更低(率比0.88),嚴重高鉀血癥事件沒有顯著增多,但試驗為開放標籤設計,且在中國農村開展。
The New England Journal of Medicine
智慧手錶脈搏不規則提醒較少見,做貼片檢查者34%確有房顫
在419,297名沒有已知心房顫動(房顫)的蘋果手錶使用者中,0.52%收到脈搏不規則提醒;返還可用心電貼片的450人中,34%確認有房顫(97.5%置信區間29至39)。提醒發出時恰有貼片記錄的,通知的陽性預測值為0.84(95%置信區間0.76至0.92),但收到提醒者中僅20.8%返還了貼片,沒有收到提醒的人未被監測,所以手錶沒有提醒並不能排除房顫。
The New England Journal of Medicine

